onlineroulettecasinogame| Minimally Invasive Medical's share price fell 6.22%: 2023 performance forecast is lowered, and it is expected to rebound in 2024
editor 2024-05-23 17:09:52 Nature 24
News summary
Minimally Invasive Medical shares plummetonlineroulettecasinogame, CITIC Construction Investment expects revenue in 2023 to fall short of expectationsonlineroulettecasinogameHowever, Nomura is optimistic about growth in 2024, and the company's convertible bond financing is expected to ease liquidity.
Newsletter text
Minimally Invasive Medical's share price has suffered a sharp drop, falling more than 6%, with the current offer price of 6onlineroulettecasinogame.8 Hong Kong dollars, with turnover reaching 1onlineroulettecasinogame.77 billion Hong Kong dollars.
Analysts at CITIC Construction Investment pointed out in a recently released report that in 2023, due to overseas supply chain challenges and the impact of domestic centralized procurement policies, the production capacity of some products of Minimally Invasive Medical will be limited, coupled with the improvement of domestic industry compliance standards, resulting in The company's revenue growth failed to fully meet market expectations. Despite this, looking forward to 2024, the company's coronary, orthopedic and heart rhythm management businesses are expected to continue to grow steadily, while the expansion of surgical robots, neurointervention, heart valve and aortic and peripheral intervention businesses is expected to drive the company's overall performance to rise rapidly. As the company continues to implement cost reduction and efficiency improvement measures, it is expected that losses will be significantly reduced in the future and eventually turn into profits. Minimally Invasive Medical recently announced a convertible bond financing agreement, a move that successfully eased the company's liquidity pressure. The company's future strategic focus is expected to shift from research and development to performance. Although the company's financial situation may show signs of improvement in the short term, the long-term debt problem remains severe, which is supported by analysis from Nomura Securities.